Skip to main content

BARCLAYS PLC

Position in TVTX — Travere Therapeutics, Inc.

CIK 312069 LONDON, X0

Position in TVTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,122,564
-$6,271,095 QoQ
Shares Held
19,760
-92.1% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#174
of 317 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TVTX Over Time

Shares Held

Position Value (USD)

Derivatives in TVTX

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$18,140,926
PutShares
610,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,706,205,173 across 455 Biotechnology names. TVTX ranks #107 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TVTX

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,122,564 19,760
2026-03-31 $18,140,926 610,600
2026-03-31 $7,393,659 248,861
2025-12-31 $8,100,520 212,000
2025-12-31 $14,119,740 369,530
2025-09-30 $8,341,147 349,002
2025-06-30 $444,000 30,000
2025-06-30 $7,822,184 528,526
2025-03-31 $14,727,229 821,832
2024-12-31 $6,908,248 396,570
2024-09-30 $2,361,064 168,768
2024-06-30 $1,531,483 186,312
2024-03-31 $1,370,505 177,757
2024-03-31 $863,520 112,000
2023-12-31 $983,506 109,400
2023-12-31 $3,477,412 386,809
2023-12-31 $1,510,320 168,000
2023-09-30 $2,580,566 288,654
2023-06-30 $3,879,674 252,583
2023-03-31 $4,560,657 202,786
2022-12-31 $3,886,049 184,786
2022-09-30 $3,373,536 136,913
2022-06-30 $619,221 25,556
2022-03-31 $1,260,178 48,901
2020-09-30 RTRX 24,386
2020-06-30 RTRX 38,992
2020-03-31 RTRX 36,792